186 related articles for article (PubMed ID: 26122172)
1. Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success.
Rekers NV; von Herrath MG; Wesley JD
Clin Immunol; 2015 Nov; 161(1):37-43. PubMed ID: 26122172
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for immune intervention trials in type 1 diabetes.
Mallone R; Roep BO
Clin Immunol; 2013 Dec; 149(3):286-96. PubMed ID: 23510725
[TBL] [Abstract][Full Text] [Related]
3. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M
J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292
[TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
5. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.
Odegard JM; Nepom GT; Wambre E
Clin Immunol; 2015 Nov; 161(1):44-50. PubMed ID: 26122171
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease.
Skog O; Korsgren S; Melhus A; Korsgren O
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):118-23. PubMed ID: 23422243
[TBL] [Abstract][Full Text] [Related]
8. DiaPep277® and immune intervention for treatment of type 1 diabetes.
Schloot NC; Cohen IR
Clin Immunol; 2013 Dec; 149(3):307-16. PubMed ID: 24090708
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes.
Creusot RJ; Battaglia M; Roncarolo MG; Fathman CG
Stem Cells; 2016 Apr; 34(4):809-19. PubMed ID: 26840009
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
11. Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study.
Speake C; Bahnson HT; Wesley JD; Perdue N; Friedrich D; Pham MN; Lanxon-Cookson E; Kwok WW; Sehested Hansen B; von Herrath M; Greenbaum CJ
Front Immunol; 2019; 10():2023. PubMed ID: 31572352
[TBL] [Abstract][Full Text] [Related]
12. Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes.
Greenbaum C; Lord S; VanBuecken D
Curr Diab Rep; 2017 Oct; 17(11):119. PubMed ID: 29039056
[TBL] [Abstract][Full Text] [Related]
13. The potential role of dendritic cells in the therapy of Type 1 diabetes.
Lee CN; Lew AM; Wu L
Immunotherapy; 2013 Jun; 5(6):591-606. PubMed ID: 23725283
[TBL] [Abstract][Full Text] [Related]
14. Treg gene signatures predict and measure type 1 diabetes trajectory.
Pesenacker AM; Chen V; Gillies J; Speake C; Marwaha AK; Sun A; Chow S; Tan R; Elliott T; Dutz JP; Tebbutt SJ; Levings MK
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730852
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Type 1 Diabetes: Why Do Current Protocols Not Halt the Underlying Disease Process?
Kolb H; von Herrath M
Cell Metab; 2017 Feb; 25(2):233-241. PubMed ID: 27839907
[TBL] [Abstract][Full Text] [Related]
16. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
Boettler T; von Herrath M
Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
[TBL] [Abstract][Full Text] [Related]
18. Combination Immunotherapy for Type 1 Diabetes.
Bone RN; Evans-Molina C
Curr Diab Rep; 2017 Jul; 17(7):50. PubMed ID: 28534310
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for type 1 diabetes.
Frumento D; Ben Nasr M; El Essawy B; D'Addio F; Zuccotti GV; Fiorina P
J Endocrinol Invest; 2017 Aug; 40(8):803-814. PubMed ID: 28260183
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for the prevention and treatment of type 1 diabetes.
Goudy KS; Tisch R
Int Rev Immunol; 2005; 24(5-6):307-26. PubMed ID: 16318984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
